Kidney News and Research

RSS

A 'health number' that could tell about prostate disease

When it comes to staying on top of your health, doctors often tell you how important it is to "know your numbers." Blood pressure, cholesterol and body mass index can tell you a lot about your heart health, but if you're a man, you need to know one more - your PSA, or prostate-specific antigen.

18 Jun 2019

Scientists identify two genes that may play a role in prostate enlargement

For aging men, prostate enlargement is almost as common as graying hair, and yet scientists know very little about why the prostate increases in size or how the process occurs on a molecular level.

17 Jun 2019

Urinary DKK3 can improve prediction of AKI

A new renal biomarker was presented at the ERA-EDTA Congress last year: that shows that urinary DKK3 might help to identify patients who are at risk of progressive chronic kidney disease.

17 Jun 2019

$VITALE study: High-dose vitamin D effective in lowering fracture rates after kidney transplantation$

VITALE study: High-dose vitamin D effective in lowering fracture rates after kidney transplantation

Lead VITALE investigator Dr Marie Courbebaisse (Paris, France), commented, Our study shows that currently recommended doses of vitamin D are not sufficient to protect patients from the risk of fracture after kidney transplantation.

17 Jun 2019

Indigestion remedy improves survival in people with late-stage CKD

Defined as serum bicarbonate less than 22 mmol/L, metabolic acidosis is common in people with CKD stages 4-5 (eGFR < 30 ml/min/1.73 m2) and is directly related to worsening kidney function.

17 Jun 2019

New natural extract inhibits the development of diabetic nephropathy

A team of researchers have published in the Journal of Cellular Physiology that a new natural extract is able to inhibit the development of diabetic nephropathy, a kidney disease that is increasing in incidence throughout the world.

16 Jun 2019

One-fifth of U.S. surgeons still 'overusing' riskier method to create kidney dialysis access, study finds

Long-term hemodialysis is a lifesaver for approximately half a million patients in the United States with kidney failure (also known as end-stage renal disease, or ESRD) who are either waiting on or unsuitable for a kidney transplant.

From Johns Hopkins Medicine 14 Jun 2019

Disease-modifying therapy for Alport syndrome still remains an unmet need

Alport syndrome is a hereditary type IV collagen disease that leads to progressive proteinuria, renal fibrosis, and kidney failure.

13 Jun 2019

Overweight young children have a doubled risk of high blood pressure

Overweight four-year-olds have a doubled risk of high blood pressure by age six, raising the hazard of future heart attack and stroke. That's the finding of a study published today in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology.

13 Jun 2019

More screening and new treatments needed for sickle cell disease

The promise of new treatments for sickle cell disease, a group of inherited red blood cell disorders, has never been so great, but it will only be realized if there is constant investment in health policies such as programs for screening newborns, especially in sub-Saharan Africa, where most cases occur.

13 Jun 2019

Researchers provide insight into unintended consequence of immune checkpoint inhibitors

Immune checkpoint inhibitors are an emerging type of cancer immunotherapy that uses the immune system to attack cancer cells.

12 Jun 2019

The immune system in women may be different from men finds study

Research has shown that women have a different immune system from men and may respond differently to different immune disease processes.

11 Jun 2019

Study assesses potential negative effect of Ochratoxin A on embryonic development

The study shows that the presence of Ochratoxin A affects survival and decreases the proliferation of human cells in the embryonic phase

11 Jun 2019

Diabetes drug reduces cardiovascular events and kidney problems, study finds

A clinical trial that followed more than 9,900 people in 24 countries has found that the drug dulaglutide reduced cardiovascular events and kidney problems in middle-aged and older people with Type 2 diabetes.

10 Jun 2019

Rapid fluid removal from patients with failing kidneys linked to increased risk of death

The faster fluid is removed using continuous dialysis from patients with failing kidneys, the higher the likelihood they will die in the next several months, according to a study published today in JAMA Network Open by University of Pittsburgh School of Medicine researchers.

8 Jun 2019

Bariatric surgery patients at higher risk of death from substance use problems

The death rate from drug- and alcohol-related causes in people who've had Roux-en-Y gastric bypass surgery is nearly triple that of the general public, according to University of Pittsburgh research published today in Surgery for Obesity and Related Diseases, the journal of the American Society for Metabolic and Bariatric Surgery.

8 Jun 2019

Vitamin D supplement does not prevent type 2 diabetes in adults at high risk, study finds

Taking a daily vitamin D supplement does not prevent type 2 diabetes in adults at high risk, according to results from a study funded by National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health.

8 Jun 2019

Human body is a mosaic pattern of DNA mutations, say researchers

Researchers have discovered that the cells of the human body aren’t clones of a single DNA sequence, but are actually a mosaic of mutations.

7 Jun 2019

New research provides welcomed news for countless patients taking PPIs

For patients taking proton pump inhibitors to treat gastroesophageal disease (GERD) or other acid-related conditions, new research puts safety concerns to rest.

7 Jun 2019

New immunosuppressive regimens may improve outcomes for kidney transplant patients

Preliminary results from a $5.2 million clinical trial led by University of Cincinnati researchers show that the immunosuppressive drug belatacept can help safely and effectively treat kidney transplant patients without the negative long-term side effects of traditional immunosuppressive regimens, the study's leaders announced this week.

6 Jun 2019